Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Clin Oncol. Dec 10, 2014; 5(5): 845-857
Published online Dec 10, 2014. doi: 10.5306/wjco.v5.i5.845
Table 2 Evidence supporting recommended dose-fractionation schedules
IndicationRecommended scheduleSelected referencesLevel of evidence
Uncomplicated bone metastases (spine, non-spine)[15]1
8Gy/1[10,32,39,41,60,61]5
Neuropathic pain8Gy/1 or 20Gy/5[38]1
Impending SCC, RT aloneMultifraction[41]5
[36]4
Impending pathologic fracture, RT alone20-40Gy/5-20[45]1